Article info

PDF

Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus

Authors

  1. Correspondence to Professor Joan T Merrill; Joan-Merrill{at}omrf.org
View Full Text

Citation

Merrill JT, Furie R, Werth VP, et al
Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus

Publication history

  • Received June 18, 2018
  • Revision received September 13, 2018
  • Accepted October 2, 2018
  • First published November 26, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.